Board members

The Board of the Francis Crick Institute currently comprises eleven members. Click on the name of the Board member to find out more.

  1. Sir David Cooksey (Chair)

    Sir David Cooksey chairs Bechtel Ltd, the engineering construction company. Until January 2012, he was Chairman of the Board of UK Financial Investments Limited, the company set up to manage the government's investments in the banks.

    Sir David Cooksey (Chair)

    After founding venture capital firm Advent Venture Partners in 1981, he went on to hold several senior positions in the private and public sectors including Chairman of the Audit Commission, 1986 - 1995, a Director of the Bank of England, 1994 - 2005, and a Governor of the Wellcome Trust.

    In 2006 Sir David was commissioned by the government to carry out an independent review of arrangements for funding health research in the UK. The resulting report set out a vision for enhancing the effectiveness of medical research in the UK.   It was a stimulus for the founding of the Francis Crick Institute.

  2. Professor Maggie Dallman

    Professor Maggie Dallman is Principal of the Faculty of Natural Sciences at Imperial College London. She is also Professor of Immunology with an interest in understanding diseases involving excessive immunity and inflammation.

    Professor Maggie Dallman, Imperial College London

    Maggie sits on the boards of several research and health organisations including the Imperial College Healthcare NHS Trust Board; the Biotechnology and Biological Sciences Research Council (BBSRC) Strategy Advisory Board; the BBSRC Basic Sciences Underpinning Health Board (Chair); the Institute for Animal Health Scientific Advisory Board; the NC3Rs Board and the HEFC Research and Innovation Strategic Advisory Committee.

    Maggie held an MRC Senior Research Fellowship at the University of Oxford before joining Imperial College in 1994. She held increasingly senior positions in the College and was appointed to her current role in 2008.

    More about Professor Maggie Dallman at Imperial College London

  3. Jamie Dundas

    Jamie Dundas is Chairman of Jupiter Fund Management plc and a non-executive Director of Standard Chartered plc, where he chairs the Board Risk Committee.

    Jamie Dundas

    After being called to the Bar, he began his career at Morgan Grenfell, where he spent 19 years. He was Finance Director of the Hong Kong Airport Authority from 1992 to 1996 when the Authority financed and built Hong Kong's new international airport. He then joined the commercial property company MEPC, where from 1997 to 2003 he was first Finance Director and then Chief Executive.

    In the voluntary sector, he was Chairman of Macmillan Cancer Support from 2001 to 2010, and continues to serve as the charity's Deputy President. He is a former non-executive director of J Sainsbury plc and Drax plc.

  4. Dr Lynne Gailey

    Lynne Gailey currently sits on the University College London Hospitals (UCLH) Charitable Foundation Development Board giving strategic communications advice to the chief executive and tactical communications support to the fundraising team.

    Lynne Gailey, independent Board member and Trustee

    She was formerly Global Communications  Leader for GE Healthcare responsible for reputation and image. Previously Lynne spent more than three years as Director of Corporate Affairs at Amersham plc with responsibility for all aspects of communications including media relations, public affairs and internal communications. Lynne received a PhD in Chemistry and a degree in Chemistry from Leeds University.

  5. Dr Jim Smith

    Jim Smith is Deputy Chief Executive and Chief of Strategy at the Medical Research Council (MRC) and Director of the MRC's National Institute for Medical Research (NIMR), a post he took up in 2009. He was previously Professor of Developmental Biology and Director of the Gurdon Institute at the University of Cambridge, and before that had worked at NIMR from 1984 to 2000.

    Dr Jim Smith

    Jim was elected a Fellow of the Royal Society in 1993 and a Fellow of the Academy of Medical Sciences in 1998. He was awarded the EMBO medal in 1994 and the Feldberg Foundation Award in 2000.

    His current research interest is the molecular basis of mesoderm formation.

  6. Dr Harpal Kumar

    Harpal Kumar MA MEng MBA DSc is Chief Executive of Cancer Research UK, appointed in 2007 following three years as Chief Operating Officer and five years as Chief Executive of Cancer Research Technology Limited, a wholly-owned subsidiary of Cancer Research UK.

    Harpal is also Chairman of the Beatson Institute for Cancer Research in Glasgow, a Trustee of the Institute for Cancer Research in London, and serves on the Boards of the National Cancer Research Institute and the UK Clinical Research Collaboration. He co-chairs the National Awareness and Early Diagnosis Initiative and is Deputy Chair of the Advisory Board for the Cancer Reform Strategy in England.

    More about Harpal Kumar at Cancer Research UK

  7. Hilary Newiss

    Hilary Newiss qualified as a solicitor in 1981 and was formerly Head of Intellectual Property in the law firm Denton Hall, now SNR Denton. In 2000, she retired from full time practice as a lawyer and has since served on a number of public bodies in the ethics, legal and scientific research field.

    Hilary is currently deputy chair of the Human Fertilisation and Embryology Authority Appeals Committee, a member of the National Information Governance Board for Health and Social Care, a non-executive director and trustee of The Roslin Foundation, the legal member of the Animal Procedures Committee and deputy chair of the Development Board, Somerville College, Oxford.

  8. Professor Sir John Tooke

    Professor Sir John Tooke is Vice Provost (Health), Head of the UCL School of Life & Medical Sciences and Head of the UCL Medical School. He is a member of the board of UCLH and, from November 2011, will be President of The Academy of Medical Sciences.

    Sir John Tooke

    From 1987 John was Consultant Physician at the Royal Devon and Exeter Hospital NHS Trust and Professor of Vascular Medicine at Exeter University. In 2000 he was appointed inaugural Dean of the Peninsula College of Medicine and Dentistry. He joined UCL in 2009.

    John is a member of the National Institute for Health Research Advisory Board and, in 2007, led an independent UK inquiry into Modernising Medical Careers.

    More about Professor Sir John Tooke at UCL

  9. Chris Mottershead

    Chris Mottershead is Vice-Principal (Research and Innovation) at King’s College London, where he is also responsible for the natural and social science schools.  He joined King's in 2009 after retiring from BP, where he worked for 30 years. Most recently as their Global Advisor on Energy Security and Climate Change and prior to this he was Technology Vice President for the Global Gas, Power and Renewables businesses. 

    Chris Mottershead

    As well as his King’s College accountabilities, he is a non-Executive Director of the Carbon Trust, Imanova, a Governor of King's College Hospital NHS Foundation Trust and a member of the Scientific Advisory Group of the Department of Energy and Climate Change in the UK and Advisory Board of the National Centre for Atmospheric Research in the US.

    More about Chris Mottershead at King’s College London

  10. Philip Yea

    Philip Yea is the Chairman of Trustees at the British Heart Foundation and a non-Executive Director at Vodafone.

    Philip Yea

    He was Chief Executive of the private equity group 3i between 2004 and 2009 and, before then, was a partner in the private equity business of Investcorp, focusing on the performance of portfolio investments. He is a former Finance Director of Diageo, the leading drinks group. A member of the Chartered Institute of Management Accountants, Philip holds a number of advisory roles including to Prince Andrew, The Duke of York, as well as to PricewaterhouseCoopers in the UK and Bridges Ventures. 

  11. Jeremy Farrar

    Jeremy Farrar is Director of the Wellcome Trust, a global charitable foundation dedicated to achieving extraordinary improvements in health by supporting the brightest minds.   Before joining the Trust he was Director of the Oxford University Clinical Research Unit in Vietnam, where his research interests were in infectious diseases, tropical health and emerging infections.  He has contributed to 500 peer-reviewed scientific papers, and served on several World Health Organization advisory committees.

    Jeremy Farrar

    Jeremy was appointed OBE in 2005 for services to Tropical Medicine, and he has been awarded the Memorial Medal and Ho Chi Minh City Medal from the Government of Vietnam, Frederick Murgatroyd Prize for Tropical Medicine by the Royal College Physicians and the Bailey Ashford Award by the American Society for Tropical Medicine and Hygiene. He is a Fellow of the Academy of Medical Sciences, and chairs the International Severe Acute Respiratory and Emerging Infection Consortium, a global initiative to share data about emerging diseases that could become epidemics or pandemics.